嘉必优 (688089)

CABIO Biotech (Wuhan) Co., Ltd.

KSH

Tags

AIGC ConceptDeepSeekSSE Innovation IndexChemical ProductsChemical IndustrySynthetic BiologyBuyback PlansGene ConceptInfant and Child ConceptPet EconomyHigh-Performing StocksVitaminsMargin Trading and Securities LendingAssisted ReproductionFood Manufacturing

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): No data
  • Circulating A-Shares(W): No data
  • Earnings Per Share(RMB): No data
  • Net Assets Per Share(RMB): No data
  • Operating Revenue(W RMB): No data
  • Total Profit(W RMB): No data
  • **Net Profit Attributable to Parent(W RMB) **: No data
  • Net Profit Growth Rate(%): No data
  • Weighted Return on Equity(%): No data
  • Operating Cash Flow Per Share(RMB): No data
  • Undistributed Profit Per Share(RMB): No data
  • Capital Reserve Per Share(RMB): No data

2. Main Business

The main business covers:

  • Research, development, production and sales of polyunsaturated fatty acid ARA
  • Research, development, production and sales of algal oil DHA and SA
  • Research, development, production and sales of natural β-carotene and other series of products

3. Company Basic Information

  • Company Name: CABIO Biotech (Wuhan) Co., Ltd.
  • Listing Date: 2019-12-19
  • Industry: Food Manufacturing Industry
  • Address: No. 999 Gaoxin Avenue, East Lake High-tech Development Zone, Wuhan City, Hubei Province
  • Website: https://www.cabio.cn/
  • Company Profile: On August 26, 2004, Cargill Investments, Cargill Asia Pacific and Wuhan Xiwang signed the "Cargill Xiwang Bio-engineering (Wuhan) Co., Ltd. Joint Venture Contract", agreeing to jointly invest in establishing Cargill Xiwang with a total investment of 124,000,000 yuan. On September 22, 2004, Cargill Xiwang obtained the "Business License" (Registration No.: Qihedonghu Zong Zi No. 006146) issued by the Wuhan Administration for Industry and Commerce. On December 15, 2015, Daxin Accounting Firm (Special General Partnership) issued the "Capital Verification Report for CABIO Biotech (Wuhan) Co., Ltd. (Preparation)" (Daxin Yan Zi [2015] No. 2-00117) to verify the capital contribution for this overall change by net asset conversion. On December 30, 2015, CABIO obtained the re-issued "Business License" (Unified Social Credit Code: 914201007646299848) from the Hubei Administration for Industry and Commerce.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
No data No data No data No data No data

5. Concept Sectors

  • No concept sector data

Remarks

  • Data update date: 2023-10-01
  • Data source: Public market information